Library

Language
Preferred search index
Number of Hits per Page
Default Sort Criterion
Default Sort Ordering
Size of Search History
Default Email Address
Default Export Format
Default Export Encoding
Facet list arrangement
Maximum number of values per filter
Auto Completion
Feed Format
Maximum Number of Items per Feed
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Electronic Resource  (3)
  • Null-Allel  (2)
  • Dopamine  (1)
  • 1
    ISSN: 1432-1459
    Keywords: Parkinson's disease ; Controlled release ; Levodopa ; Dopamine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary In five levodopa (l-dopa)-treated patients with Parkinson's disease with severe fluctuations of motor performance, plasma l-dopa as well as dopamine levels were measured during 2 days, first under optimal standard l-dopa with peripheral decarboxylase inhibitor (PDI) and then after a dose adjustment period using slow-release l-dopa/benserazide (Madopar HBS) in an open inpatient trial. Three patients benefited from the slow-release preparation; two patients deteriorated with a tendency to have an unpredictable response, a delay to turn “on” with the first dose in the morning, as well as an increase in dyskinesia corresponding to l-dopa cumulation during the day. These problems were subsequently also seen during the follow-up period of 1 year in those patients who benefited from Madopar HBS as inpatients. This might indicate that patient compliance is more difficult with the new formulation. After 1 year all patients had returned to their previous standard l-dopa/PDI treatment. l-Dopa levels continued to fluctuate, but to a lesser degree with Madopar HBS. The equivalent l-dopa dosage had to be increased by 56% (29–100%) with Madopar HBS while mean dopamine levels increased in four patients (by 47–257%) without the occurrence of peripheral side-effects. This implies that with the new formulation more l-dopa is metabolized to dopamine and explains the necessity to increase the equivalent l-dopa dosage.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    International journal of legal medicine 103 (1990), S. 609-612 
    ISSN: 1437-1596
    Keywords: PGM-phenotypes ; Enzyme-activity ; Silent allel ; PGM-Phänotypen ; Enzym-Aktivität ; Null-Allel
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine , Law
    Description / Table of Contents: Zusammenfassung Die Enzymaktivität der erythrozytären Phosphogluco-mutase wurde in 142 Hämolysaten bestimmt. Die PGM-Phänotypen wurden mittels Isoelektrofokussierung auf Polyacrylamid-Gel ermittelt. Dabei konn-ten 10 verschiedene Phänotypen dargestellt werden. Die mittlere Enzymakti-vität dieser 10 Phänotypen weist signifikante Unterschiede auf. Ein stummes Allel bzw. ein Allel mit reduzierter PGM-Aktivität wurde nicht festgestellt. Es zeigte sich eine Korrelataion zwischen Enzymaktivität und isoelektrischem Punkt der vier Homozygoten.
    Notes: Summary The enzyme activity of phosphoglucomutase (PGM) has been investigated in red cell haemolysates from 142 individuals and compared to the sub-type as determined by isoelectric focusing. The 10 phenotypes showed significant differences in PGM-activity which indicates that there is a correlation between the level of activity and the isolelectric point of homozygotes. No indication of silent alleles or alleles with reduced activity was found in this collective.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    International journal of legal medicine 103 (1990), S. 609-612 
    ISSN: 1437-1596
    Keywords: PGM-phenotypes ; Enzyme-activity ; Silent allel ; PGM-Phanotypen ; Enzym-Aktivität ; Null-Allel
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine , Law
    Description / Table of Contents: Zusammenfassung Die Enzymaktivität der erythrozytdren Phosphoglucomutase wurde in 142 Hdmolysaten bestimmt. Die PGM-Phänotypen wurden mittels Isoelektrofokussierung auf Polyacrylamid-Gel ermittelt. Dabei konnten 10 verschiedene Phanotypen dargestellt werden. Die mittlere Enzymaktivität dieser 10 Phänotypen weist signifikante Unterschiede auf. Ein stummes Allel bzw. ein Allel mit reduzierter PGM-Aktivität wurde nicht festgestellt. Es zeigte sich eine Korrelataion zwischen Enzymaktivitat und isoelektrischem Punkt der vier Homozygoten.
    Notes: Summary The enzyme activity of phosphoglucomutase (PGM) has been investigated in red cell haemolysates from 142 individuals and compared to the sub-type as determined by isoelectric focusing. The 10 phenotypes showed significant differences in PGM-activity which indicates that there is a correlation between the level of activity and the isolelectric point of homozygotes. No indication of silent alleles or alleles with reduced activity was found in this collective.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...